Abstract
COVID-19 represents a collection of disease endotypes stemming from infection with SARS-CoV-2 and thus requires precision medicine approaches to target specific viral variants and stages of illness. In this issue, van Laarhoven et al. 1 describe five immunocompromised patients with prolonged COVID-19 successfully treated with interferon gamma (IFNγ).
All Keywords
【초록키워드】 COVID-19, Immunocompromised patient, viral variant, disease, interferon gamma, Precision, stages, IFNγ, Stage, approach, FIVE, treated, infection with SARS-CoV-2, 【제목키워드】 COVID-19,
【초록키워드】 COVID-19, Immunocompromised patient, viral variant, disease, interferon gamma, Precision, stages, IFNγ, Stage, approach, FIVE, treated, infection with SARS-CoV-2, 【제목키워드】 COVID-19,
{{{ 추상적인 }}}
COVID-19는 SARS-CoV-2 감염으로 인한 질병 엔도타입의 집합을 나타내므로 특정 바이러스 변이체 및 질병 단계를 대상으로 하는 정밀 의학 접근이 필요합니다. 이 문제에서 van Laarhoven et al. 1은 인터페론 감마(IFNγ)로 성공적으로 치료된 장기간 COVID-19에 걸린 5명의 면역 저하 환자를 설명합니다.